Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Social Psychiatry and Psychiatric Epidemiology
Published in: Social Psychiatry and Psychiatric Epidemiology 7/2017

01-07-2017 | Original Paper

Drug abuse-associated mortality across the lifespan: a population-based longitudinal cohort and co-relative analysis

Authors: Kenneth S. Kendler, Henrik Ohlsson, Kristina Sundquist, Jan Sundquist

Published in: Social Psychiatry and Psychiatric Epidemiology | Issue 7/2017

Login to get access

Abstract

Purpose

Nationwide data have been lacking on drug abuse (DA)-associated mortality. We do not know the degree to which this excess mortality results from the characteristics of drug-abusing individuals or from the effects of DA itself.

Method

DA was assessed from medical, criminal, and prescribed drug registries. Relative pairs discordant for DA were obtained from the Multi-Generation and Twin Registers. Mortality was obtained from the Swedish Mortality registry.

Results

We examined all individuals born in Sweden 1955–1980 (n = 2,696,253), 75,061 of whom developed DA. The mortality hazard ratio (mHR) (95% CIs) for DA was 11.36 (95% CIs, 11.07–11.66), substantially higher in non-medical (18.15, 17.51–18.82) than medical causes (8.05, 7.77–8.35) and stronger in women (12.13, 11.52–12.77) than in men (11.14, 10.82–11.47). Comorbid smoking and alcohol use disorder explained only a small proportion of the excess DA-associated mortality. Co-relative analyses demonstrated substantial familial confounding in the DA–mortality association with the strongest direct effects seen in middle and late-middle ages. The mHR was highest for opiate abusers (24.57, 23.46–25.73), followed by sedatives (14.19, 13.11–15.36), cocaine/stimulants (12.01, 11.36–12.69), and cannabis (10.93, 9.94–12.03).

Conclusion

The association between registry-ascertained DA and premature mortality is very strong and results from both non-medical and medical causes. This excess mortality arises both indirectly—from characteristics of drug-abusing persons—and directly from the effects of DA. Excess mortality of opiate abuse was substantially higher than that observed for all other drug classes. These results have implications for interventions seeking to reduce the large burden of DA-associated premature mortality.
Appendix
Available only for authorised users
Literature
1.
Degenhardt L, Hall W (2012) Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 379(9810):55–70CrossRefPubMed
2.
Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, Freedman G, Burstein R, Johns N, Engell RE, Flaxman A, Murray CJ, Vos T (2013) Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 382(9904):1564–1574CrossRefPubMed
3.
Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME (2015) Mental, neurological, and substance use disorders, 3rd edn. World Bank Group, Washington, D.C.
4.
Larm P, Hodgins S, Larsson A, Samuelson YM, Tengstrom A (2008) Long-term outcomes of adolescents treated for substance misuse. Drug Alcohol Depend 96(1–2):79–89CrossRefPubMed
5.
Bargagli AM, Hickman M, Davoli M, Perucci CA, Schifano P, Buster M, Brugal T, Vicente J (2006) Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health 16(2):198–202CrossRefPubMed
6.
Degenhardt L, Singleton J, Calabria B, McLaren J, Kerr T, Mehta S, Kirk G, Hall WD (2011) Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend 113(2–3):88–95CrossRefPubMed
7.
Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J (2011) Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 106(1):32–51CrossRefPubMed
8.
Perucci CA, Bargagli AM, Davoli M, Sperati A, Hartnoll R, Vicente J (2000) Mortality of drug users in the EU: coordination of implementation of new cohort studies, follow-up and analysis of existing cohorts and development of new methods and outputs. Report No.: EMCDDA Scientific report: EMCDDA CT.99.EP.07/CT.00.EP.13. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Lisboa
9.
Ridolfo B, Stevenson C (2001) The Quantification of drug-caused mortality and morbidity in Australia, 1998. Canberra, AIHW. Drug Statistics Series no. 7. Cat. no. PHE 29. 6-1-2016
10.
Lindblad R, Hu L, Oden N, Wakim P, Rosa C, VanVeldhuisen P (2016) Mortality rates among substance use disorder participants in clinical trials: pooled analysis of twenty-two clinical trials within the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat 70:73–80CrossRefPubMed
11.
Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004) Actual causes of death in the United States, 2000. JAMA 291(10):1238–1245CrossRefPubMed
12.
Case A, Deaton A (2015) Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci USA 112(49):15078–15083CrossRefPubMedPubMedCentral
13.
Singleton J, Degenhardt L, Hall W, Zabransky T (2009) Mortality among amphetamine users: a systematic review of cohort studies. Drug Alcohol Depend 105(1–2):1–8CrossRefPubMed
14.
Calabria B, Degenhardt L, Hall W, Lynskey M (2010) Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev 29(3):318–330CrossRefPubMed
15.
Lopez-Quintero C, Roth KB, Eaton WW, Wu LT, Cottler LB, Bruce M, Anthony JC (2015) Mortality among heroin users and users of other internationally regulated drugs: a 27-year follow-up of users in the Epidemiologic Catchment Area Program household samples. Drug Alcohol Depend 156:104–111CrossRefPubMedPubMedCentral
16.
Bargagli AM, Sperati A, Davoli M, Forastiere F, Perucci CA (2001) Mortality among problem drug users in Rome: an 18-year follow-up study, 1980–1997. Addiction 96(10):1455–1463CrossRefPubMed
17.
Rodriguez DF, Carrera MR, Navarro M, Koob GF, Weiss F (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276(5321):2050–2054CrossRef
18.
Fergusson DM, Horwood LJ (2000) Cannabis use and dependence in a New Zealand birth cohort. N Z Med J 113(1109):156–158PubMed
19.
Agrawal A, Jacobson KC, Prescott CA, Kendler KS (2004) A twin study of personality and illicit drug use and abuse/dependence. Twin Res 7(1):72–81CrossRefPubMed
20.
Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, Hasin DS (2015) Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry 72(8):757–766CrossRefPubMedPubMedCentral
21.
22.
Ljungquist B, Berg S, Lanke J, McClearn GE, Pedersen NL (1998) The effect of genetic factors for longevity: a comparison of identical and fraternal twins in the Swedish Twin Registry. J Gerontol Med Sci 53A(6):M441–M446CrossRef
23.
Kendler KS, Ohlsson H, Sundquist J, Sundquist K (2016) Alcohol use disorder and mortality across the lifespan: a longitudinal cohort and co-relative analysis. JAMA Psychiatry 73(6):575–581CrossRefPubMedPubMedCentral
24.
SAS Institute I (2011) SAS/STAT User’s Guide, version 9.3. SAS Institute Inc, SAS Institute Inc, Cary
25.
Onyeka IN, Beynon CM, Hannila ML, Tiihonen J, Fohr J, Tuomola P, Kuikanmaki O, Tasa N, Paasolainen M, Kauhanen J (2014) Patterns and 14-year trends in mortality among illicit drug users in Finland: the HUUTI study. Int J Drug Policy 25(6):1047–1053CrossRefPubMed
26.
Cottler LB, Hu H, Smallwood BA, Anthony JC, Wu LT, Eaton WW (2016) Nonmedical opioid pain relievers and all-cause mortality: a 27-year follow-up from the epidemiologic catchment area study. Am J Public Health 106(3):509–516CrossRefPubMedPubMedCentral
27.
Oyefeso A, Ghodse H, Clancy C, Corkery J, Goldfinch R (1999) Drug abuse-related mortality: a study of teenage addicts over a 20-year period. Soc Psychiatry Psychiatr Epidemiol 34(8):437–441CrossRefPubMed
28.
Fugelstad A, Annell A, Rajs J, Agren G (1997) Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981–1992. Acta Psychiatr Scand 96(3):169–175CrossRefPubMed
29.
Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M (2013) Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ 91(2):102–123CrossRefPubMedPubMedCentral
30.
Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP (2008) Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 372(9651):1733–1745CrossRefPubMed
31.
Kringlen E, Torgersen S, Cramer V (2001) A Norwegian psychiatric epidemiological study. Am J Psychiatry 158(7):1091–1098CrossRefPubMed
32.
Rounsaville BJ, Kosten TR, Weissman MM, Prusoff B, Pauls D, Anton SF, Merikangas K (1991) Psychiatric disorders in relatives of probands with opiate addiction. Arch Gen Psychiatry 48(1):33–42CrossRefPubMed
33.
Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, Zhang H, O’Malley SS, Rounsaville BJ (1998) Familial transmission of substance use disorders. Arch Gen Psychiatry 55(11):973–979CrossRefPubMed
34.
Bierut LJ, Dinwiddie SH, Begleiter H, Crowe RR, Hesselbrock V, Nurnberger JI Jr, Porjesz B, Schuckit MA, Reich T (1998) Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch Gen Psychiatry 55(11):982–988CrossRefPubMed
Metadata
Title
Drug abuse-associated mortality across the lifespan: a population-based longitudinal cohort and co-relative analysis
Authors
Kenneth S. Kendler
Henrik Ohlsson
Kristina Sundquist
Jan Sundquist
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
Social Psychiatry and Psychiatric Epidemiology / Issue 7/2017
Print ISSN: 0933-7954
Electronic ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-017-1398-5

Other articles of this Issue 7/2017

Social Psychiatry and Psychiatric Epidemiology 7/2017 Go to the issue

Original Paper

Depressive symptom trajectories in the first 10 years of diabetes diagnosis: antecedent factors and link with future disability in Taiwan

Original Paper

The epidemiology of alcohol use in Izmir, Turkey: drinking pattern, impairment and help-seeking

Original Paper

Consumption of low-fat dairy, but not whole-fat dairy, is inversely associated with depressive symptoms in Japanese adults

Original Paper

Physical, sexual and social health factors associated with the trajectories of maternal depressive symptoms from pregnancy to 4 years postpartum

Original Paper

The impact of psychological factors on recovery from injury: a multicentre cohort study

Original Paper

Prevalence and characteristics of self-reported physical and mental disorders among adults with hearing loss in Denmark: a national survey